Zobrazeno 1 - 6
of 6
pro vyhledávání: '"E. M. Volodicheva"'
Autor:
E. S. Nesterova, S. K. Kravchenko, A. M. Kovrigina, E. G. Gemdzhian, L. V. Plastinina, Ya. K. Mangasarova, F. E. Babaeva, A. E. Misyurina, O. V. Margolin, A. U. Magomedova, V. I. Vorobiev, D. S. Maryin, E. A. Baryakh, Yu. Yu. Polyakov, P. A. Zeynalova, E. M. Volodicheva, N. N. Glonina, N. V. Minaeva, G. A. Davydova, V. G. Savchenko
Publikováno v:
Онкогематология, Vol 13, Iss 3, Pp 10-24 (2018)
Background. Follicular lymphoma (FL) is the most common type of indolent lymphomas and accounts for 20–30 % of all non-Hodgkin’s lymphomas detected. High risk of recurrence and elderly patients make it difficult to choose induction therapy for FL
Externí odkaz:
https://doaj.org/article/cf0dfc1037f240a49382053175c77ec2
Autor:
I. A. Lisukov, A. A. Maschan, A. V. Shamardina, T. V. Chagorova, I. L. Davydkin, T. M. Sycheva, T. P. Zagoskina, E. V. Karyagina, G. N. Salogub, M. T. Savinova, T. V. Shelekhova, L. G. Kovaleva, T. V. Shneyder, A. N. Unzhekova, E. E. Kuznetsova, Yu. V. Shatokhin, M. O. Ivanova, E. Yu. Vinogradova, E. M. Volodicheva, I. V. Markova, O. V. Kanyukova, K. M. Abdulkadyrov, Yu. A. Sedlova, S. M. Osyunikhina, K. D. Kaplanov, N. V. Tsvetaeva, A. R. Akhmadeev, O. S. Uspenskaya, A. D. Kulagin, N. V. Medvedeva, A. G. Rumyantsev, B. V. Afanasiev
Publikováno v:
Онкогематология, Vol 8, Iss 2, Pp 61-69 (2014)
Primary immune thrombocytopenia (ITP) is a rare (orphan) blood disease. Most frequent manifestations of ITP are purpura, petechiae and bleedings with many patients have either no symptoms or minimal bleedings manifestation. The management of ITP vari
Externí odkaz:
https://doaj.org/article/8486090d30434d0b8dce282be0f263c6
Autor:
E S Nesterova, E I Dubrovin, Eduard G. Gemdzhian, K D Kaplanov, Vera A. Zherebtsova, Vladimir I. Vorobyev, S K Kravchenko, E M Volodicheva
Publikováno v:
Терапевтический архив, Vol 91, Iss 7, Pp 41-51 (2019)
Mantle cell lymphoma (MCL) is aggressive B-cell neoplasm diagnosed predominantly among older men. R-CHOP-like regimens allow to achieve high response rate, but the overall survival (OS) are disappointingly short - 3-4 years. An addition of high - dos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b55f7e90d5faa5cefb151b121664f96c
https://pubmed.ncbi.nlm.nih.gov/32598735
https://pubmed.ncbi.nlm.nih.gov/32598735
Autor:
Ya K Mangasarova, S K Kravchenko, E M Volodicheva, Aminat U. Magomedova, Vladimir I. Vorobyev, E S Nesterova
Publikováno v:
Терапевтический архив, Vol 88, Iss 7, Pp 37-42 (2016)
to evaluate the efficiency of the R-DA-EPOCH-21 + R-DHAP protocol and autologous hematopoietic stem cell transplantation (a BEAM conditioning mode) in first-line therapy for primary mediastinal large B-cell lymphoma (PMBCL).In 2013 to 2016, the inves
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b439bdb32cf24ec2a77f0fa0271c59b5
https://pubmed.ncbi.nlm.nih.gov/27459613
https://pubmed.ncbi.nlm.nih.gov/27459613
Autor:
E N, Parovichnikova, G A, Kliasova, A N, Sokolov, V V, Troitskaia, A V, Kokhno, L A, Kuz'mina, I I, Shaforostova, V V, Ryzhko, S K, Kravchenko, S N, Bondarenko, V A, Lapin, A S, Pristupa, T S, Konstantinova, T P, Zagoskina, I V, Ialykomov, V I, Moskov, L V, Anchukova, T S, Kaporskaia, E M, Volodicheva, K D, Kaplanov, E V, Kondakova, O S, Samoĭlova, L V, Gavrilova, S M, Kulikov, V G, Savchenko
Publikováno v:
Терапевтический архив, Vol 84, Iss 7, Pp 10-15 (2012)
Aim. To give the preliminary results of the AML-01.10 Russian multicenter randomized trial to treat adult acute myeloid leukemia (AML), the basic principle of which is to use high-dose anthracycline antibiotics in induction/consolidation. Subjects an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::04d183241910784b520cdf291823fb25
https://ter-arkhiv.ru/0040-3660/article/view/31036
https://ter-arkhiv.ru/0040-3660/article/view/31036
Autor:
V I Vorobyev, E G Gemdzhian, E I Dubrovin, E S Nesterova, K D Kaplanov, E M Volodicheva, V A Zherebtsova, S K Kravchenko
Publikováno v:
Терапевтический архив, Vol 91, Iss 7, Pp 41-51 (2019)
Mantle cell lymphoma (MCL) is aggressive B-cell neoplasm diagnosed predominantly among older men. R-CHOP-like regimens allow to achieve high response rate, but the overall survival (OS) are disappointingly short - 3-4 years. An addition of high - dos
Externí odkaz:
https://doaj.org/article/18f6baf088f340b4bc9d91714f87ae71